Weekly Headlines: Gene Therapies for IRDs Receive FDA Rare Pediatric Disease Designations
Gene Therapies for IRDs Receive FDA Rare Pediatric Disease Designations • Ultrasonic Sensor Device Launched for Loss of Side Vision • Ocuvex Therapeutics Acquires Visiox Pharmaceuticals